TW202408557A - Composition for boosting immunity and use thereof - Google Patents
Composition for boosting immunity and use thereof Download PDFInfo
- Publication number
- TW202408557A TW202408557A TW111130782A TW111130782A TW202408557A TW 202408557 A TW202408557 A TW 202408557A TW 111130782 A TW111130782 A TW 111130782A TW 111130782 A TW111130782 A TW 111130782A TW 202408557 A TW202408557 A TW 202408557A
- Authority
- TW
- Taiwan
- Prior art keywords
- shrimp
- composition
- pleurotus eryngii
- strain
- lactobacillus plantarum
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 230000036039 immunity Effects 0.000 title claims abstract description 19
- 241000238557 Decapoda Species 0.000 claims abstract description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 4
- 244000252132 Pleurotus eryngii Species 0.000 claims description 48
- 235000001681 Pleurotus eryngii Nutrition 0.000 claims description 38
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 34
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 34
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 34
- 230000037396 body weight Effects 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 7
- 238000011161 development Methods 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 abstract description 4
- 229940039696 lactobacillus Drugs 0.000 abstract description 4
- 241000222350 Pleurotus Species 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 241000238553 Litopenaeus vannamei Species 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 241000607594 Vibrio alginolyticus Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 102000016943 Muramidase Human genes 0.000 description 6
- 108010014251 Muramidase Proteins 0.000 description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000010335 lysozyme Nutrition 0.000 description 6
- 229960000274 lysozyme Drugs 0.000 description 6
- 239000004325 lysozyme Substances 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 5
- 238000009313 farming Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 4
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 4
- 240000001462 Pleurotus ostreatus Species 0.000 description 4
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000000087 hemolymph Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 241000607618 Vibrio harveyi Species 0.000 description 3
- 239000002154 agricultural waste Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000024932 T cell mediated immunity Effects 0.000 description 2
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241001647146 Crangon septemspinosa Species 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000238562 Farfantepenaeus aztecus Species 0.000 description 1
- 241000335026 Fenneropenaeus penicillatus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001327110 Macrobrachium rosenbergii Species 0.000 description 1
- 241001124325 Marsupenaeus japonicus Species 0.000 description 1
- 241001454429 Metapenaeus ensis Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000121184 Monodon Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000241034 Palaemon pugio Species 0.000 description 1
- 241000238552 Penaeus monodon Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 241000434037 Volva Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AVWJKAIFMUEKMH-UHFFFAOYSA-L calcium hydrogen phosphate phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O.OP([O-])([O-])=O AVWJKAIFMUEKMH-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本發明係關於一種組合物,尤其是一種用以提升免疫能力的組合物。本發明另關於該組合物用以製備提升蝦體免疫能力之藥物的用途。The present invention relates to a composition, especially a composition for improving immunity. The present invention also relates to the use of the composition for preparing a medicine for improving the immunity of shrimps.
近年來,台灣蝦類養殖蓬勃發展,蝦體不僅可以作為食物來源,亦可以外銷為國家帶來豐富的經濟效益。由於蝦體養殖快速發展,而限於土地價格高,養殖業者須採用高密度養殖,以降低成本。In recent years, Taiwan's shrimp farming has been booming. Shrimp bodies can not only be used as a food source, but can also be exported, bringing rich economic benefits to the country. Due to the rapid development of shrimp farming and high land prices, farmers must adopt high-density farming to reduce costs.
高密度的養殖方式會造成養殖環境惡化,使蝦體之間容易相互傳染疾病,因而會使蝦體的死亡率上升;為了降低死亡率,養殖業者常會於飼料中添加抗生素,然而抗生素的濫用,不僅是導致食用者攝取蝦體而發生過敏的原因,亦可能會誘發病原菌產生抗藥性,因此仍需進一步的改善。High-density farming methods can cause the farming environment to deteriorate, making it easier for shrimps to spread diseases to each other, thus increasing the shrimp mortality rate. In order to reduce the mortality rate, farmers often add antibiotics to the feed. However, the abuse of antibiotics not only causes consumers to develop allergies after ingesting shrimps, but may also induce pathogens to develop drug resistance. Therefore, further improvement is still needed.
為解決上述問題,本發明的目的是提供一種用以提升免疫能力的組合物,係可以提升蝦類之免疫能力者。In order to solve the above problems, the object of the present invention is to provide a composition for improving immunity, which can improve the immunity of shrimps.
本發明的次一目的是提供前述組合物的用途,係可以供投予一蝦體,以免除抗生素的使用者。Another object of the present invention is to provide a use of the aforementioned composition, which can be administered to a shrimp to avoid the need for antibiotic users.
本發明的用以提升免疫能力的組合物,包含:一杏鮑菇萃取物,該杏鮑菇萃取物係以水於沸騰的狀態下萃取一杏鮑菇樣品獲得;及一植物乳桿菌7-40菌株,該植物乳桿菌7-40菌株係寄存於中華民國食品工業發展研究所,該植物乳桿菌7-40菌株的寄存編號為BCRC 911128。舉例而言,每公斤的組合物可以包含5~6公克的杏鮑菇萃取物及10 8CFU的植物乳桿菌7-40菌株。 The composition for enhancing immunity of the present invention comprises: an extract of King Pleurotus eryngii, which is obtained by extracting a King Pleurotus eryngii sample with water under boiling state; and a strain of Lactobacillus plantarum 7-40, which is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number of the strain of Lactobacillus plantarum 7-40 is BCRC 911128. For example, each kilogram of the composition may contain 5-6 grams of King Pleurotus eryngii extract and 10 8 CFU of the strain of Lactobacillus plantarum 7-40.
據此,本發明的組合物包含該杏鮑菇萃取物及該植物乳桿菌7-40菌株,因此可以藉由二者的加乘作用,達成有效提升蝦類的免疫能力之功效。Accordingly, the composition of the present invention includes the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain. Therefore, the effect of effectively improving the immunity of shrimps can be achieved through the additive effect of the two.
本發明的用以提升免疫能力的組合物,其中,該杏鮑菇樣品係可以為一杏鮑菇菌托樣品。如此,使原本被認定為農業廢棄物的菌托具有新的經濟價值,達成為菌托創造新的經濟出路之功效。In the composition for enhancing immunity of the present invention, the Pleurotus ostreatus sample can be a Pleurotus ostreatus cultivar sample. In this way, the cultivar cultivar, which was originally considered as agricultural waste, has a new economic value, achieving the effect of creating a new economic outlet for the cultivar cultivar.
本發明的組合物的用途,係用以製備提升蝦體免疫能力之藥物,該組合物係投予一蝦體,以增強該蝦體之免疫能力。The use of the composition of the present invention is to prepare a drug for enhancing the immune ability of shrimp. The composition is administered to a shrimp to enhance the immune ability of the shrimp.
據此,藉由該杏鮑菇萃取物及該植物乳桿菌7-40菌株的共同使用,可以促進蝦類的細胞免疫反應(例如提升血球細胞溶菌酶活性),因此當受到溶藻弧菌等病原菌的感染時,可以降低蝦類遭受病原菌攻擊所造成之死亡,是以可以降低養殖業者於養殖過程中的抗生素使用量,為本發明之功效。Accordingly, by using the King Oyster Mushroom extract and the Lactobacillus plantarum 7-40 strain together, the cellular immune response of shrimps can be promoted (for example, the activity of lysozyme in blood cells can be enhanced). Therefore, when the shrimps are infected by pathogens such as Vibrio alginolyticus, the death rate caused by the attack of pathogens can be reduced. Therefore, the amount of antibiotics used by farmers in the breeding process can be reduced, which is the effect of the present invention.
本發明的組合物的用途,其中,該組合物係能夠以經口餵食的方式投予該蝦體,較佳可以與一飼料混合形成一混合物,並與該飼料共同投予該蝦體;如此該組合物可以直接投於養殖水中,使該蝦體可以自由攝食,提升投予該組合物的便利性。The use of the composition of the present invention, wherein the composition can be administered to the shrimp body in an oral feeding manner, preferably it can be mixed with a feed to form a mixture, and administered to the shrimp body together with the feed; so The composition can be directly added to the culture water, so that the shrimp body can feed freely, thereby improving the convenience of administering the composition.
本發明的組合物的用途,其中,該杏鮑菇萃取物係以每天每公克之蝦體重投予300 μg之劑量投予該蝦體,該植物乳桿菌7-40菌株以每天每公克之蝦體重投予6,000 CFU之劑量投予該蝦體,且連續投予56~60天;如此藉由該組合物的投予劑量而具有較佳的提升蝦體之免疫能力的效果。The use of the composition of the present invention, wherein the King Pleurotus eryngii extract is administered to the shrimp at a dosage of 300 μg per gram of shrimp weight per day, and the Lactobacillus plantarum 7-40 strain is administered to the shrimp at a dosage of 6,000 CFU per gram of shrimp weight per day, and the administration is continued for 56 to 60 days; thus, the administration dosage of the composition has a better effect of enhancing the immune ability of the shrimp.
為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式作詳細說明:In order to make the above and other purposes, features and advantages of the present invention more clearly understood, the following is a preferred embodiment of the present invention, and is described in detail with reference to the accompanying drawings:
本發明所述「蝦類」係可以指養殖蝦,包含但不限於,太平洋白蝦( Litopenaeus vannamei)、草蝦( Penaeus monodon)、斑節蝦( Marsupenaeus japonicus)、中國草蝦( Fenneropenaeus chinensis)、印度對蝦( Fenneropenaeus indicus)、沙蝦( Metapenaeus ensis barbata)、紅尾蝦( Penaeus penicillatus)及淡水長臂大蝦( Macrobrachium rosenbergii)。 The "shrimps" mentioned in the present invention may refer to farmed shrimps, including but not limited to, Pacific white shrimp ( Litopenaeus vannamei ), grass shrimp ( Penaeus monodon ), monodon shrimp ( Marsupenaeus japonicus ), Chinese grass shrimp ( Fenneopenaeus chinensis ), Indian shrimp ( Fenneopenaeus indicus ), sand shrimp ( Metapenaeus ensis barbata ), red tail shrimp ( Penaeus penicillatus ) and freshwater long-armed giant shrimp ( Macrobrachium rosenbergii ).
本發明的用以提升免疫能力的組合物之一實施例係可以包含:一杏鮑菇萃取物及一植物乳桿菌( Lactobacillus plantarum)菌株,以藉由二者的加乘作用(synergestic effect),有效提升蝦類的免疫能力。 One embodiment of the composition for improving immunity of the present invention may include: an extract of Pleurotus eryngii and a strain of Lactobacillus plantarum , so that through the synergestic effect of the two, Effectively improve the immunity of shrimps.
詳而言之,該杏鮑菇萃取物係可以指由水萃取一杏鮑菇( Pleurotus eryngii)樣品所獲得之產物。 Specifically, the Pleurotus eryngii extract may refer to a product obtained by extracting a Pleurotus eryngii sample with water.
較佳地,在以水進行萃取之前,工者可以先將該杏鮑菇樣品可以預先碎成粉粒(粒徑約為0.5~1.0 cm),以增加該杏鮑菇樣品與水之接觸表面積,藉此提升後續萃取之萃取效率。Preferably, before extracting with water, workers can first crush the king oyster mushroom sample into powder (particle size is about 0.5-1.0 cm) to increase the contact surface area between the king oyster mushroom sample and water. , thereby improving the extraction efficiency of subsequent extractions.
舉例而言,工者可以取100公克之杏鮑菇樣品混合200~250毫升之水,於沸騰的狀態下萃取15~20分鐘,上述萃取亦可以重複數次,使該杏鮑菇樣品所含之活性成分可以完整溶於水中,此為本發明所屬技術領域中具有通常知識者所廣泛應用,在此不加以贅述。For example, workers can take 100 grams of King Oyster Mushroom sample and mix it with 200-250 milliliters of water, and extract it for 15-20 minutes under boiling conditions. The above extraction can also be repeated several times so that the active ingredients contained in the King Oyster Mushroom sample can be completely dissolved in water. This is widely used by those with ordinary knowledge in the technical field to which the present invention belongs, and will not be elaborated here.
前述之杏鮑菇萃取液可以再藉由離心(例如於4℃的溫度下,以14,400×g的轉速離心20分鐘)以去除不溶物,在冷卻至室溫之後,即可以將該杏鮑菇萃取液儲存於4℃備用。The aforementioned Pleurotus eryngii extract can be further centrifuged (for example, at 4°C and 14,400×g for 20 minutes) to remove insoluble matter. After cooling to room temperature, the Pleurotus eryngii extract can be stored at 4°C for future use.
值得注意的是,於本實施例中,係選用一杏鮑菇菌托樣品作為該杏鮑菇樣品。一般而言,杏鮑菇等菇蕈類係生長於一基質上,露出的形狀像是一把雨傘,主要包含傘狀的菌蓋(cap)、柱狀的菌柄(stem)及埋藏在該基質中的菌絲(mycelium),該菌蓋的下緣具有皺褶,被稱為菌摺(gill),包含數十萬個孢子(spore)。又,在菌柄及菌絲之間,存在有外徑略大於該菌柄的外徑、且亦露出於該基質之外的菌托(volva)。在採收杏鮑菇時,工者通常不會自該基質將杏鮑菇連同菌絲一同挖出,而僅會取包含該菌柄及該菌蓋的部分,因此該杏鮑菇菌托樣品通常僅被認定為採收杏鮑菇之後剩下的農業廢棄物。It is worth noting that in this embodiment, a Pleurotus eryngii mushroom holder sample is selected as the Pleurotus eryngii sample. Generally speaking, mushrooms such as Pleurotus eryngii grow on a substrate, and the exposed shape is like an umbrella, mainly including an umbrella-shaped cap (cap), a columnar stem (stem), and a mushroom buried in the substrate. The mycelium in the matrix has a wrinkled lower edge called the gill, which contains hundreds of thousands of spores. In addition, between the stipe and the hyphae, there is a volva whose outer diameter is slightly larger than that of the stipe and which is also exposed outside the matrix. When harvesting Pleurotus eryngii, workers usually do not dig out the Pleurotus eryngii together with the mycelium from the substrate, but only take the part containing the stipe and the cap. Therefore, the sample of the Pleurotus eryngii stipe is Usually identified only as the agricultural waste left after harvesting king oyster mushrooms.
又,該植物乳桿菌菌株可以為一植物乳桿菌7-40菌株,該植物乳桿菌7-40菌株業已於2022年05月12日寄存於中華民國食品工業發展研究所(寄存編號為BCRC 911128)。需要說明的是,該植物乳桿菌7-40菌株的菌學特徵業已公開於 邱秋霞「 Lactobacillus plantarumNTU102生理特性及其在保健食品與水產養殖應用之探討」博士論文(其中所載之 Lactobacillus plantarumNTU102即為該植物乳桿菌7-40菌株),於此不再贅述。 In addition, the Lactobacillus plantarum strain can be a Lactobacillus plantarum 7-40 strain. The Lactobacillus plantarum 7-40 strain has been deposited at the Food Industry Development Institute of the Republic of China on May 12, 2022 (deposit number is BCRC 911128) . It should be noted that the mycological characteristics of the Lactobacillus plantarum 7-40 strain have been disclosed in Qiu Qiuxia's doctoral thesis "Discussion on the Physiological Characteristics of Lactobacillus plantarum NTU102 and its Application in Health Food and Aquaculture" ( the Lactobacillus plantarum NTU102 contained in it is This is the Lactobacillus plantarum 7-40 strain), which will not be described again here.
該組合物係可以供投予一蝦體,例如能夠以經口餵食的方式投予該蝦體,使該蝦體可以自由攝食該杏鮑菇萃取物及該植物乳桿菌7-40菌株,進而使該杏鮑菇萃取物及該植物乳桿菌7-40菌株能夠共同作用以提升該蝦體的免疫能力﹝例如,提升血球細胞的溶菌酶(lysozyme)活性﹞,因此當該蝦體受到溶藻弧菌等病原菌的感染時,可以降低該蝦體遭受病原菌攻擊所造成之死亡。The composition can be administered to a shrimp, for example, by oral feeding, so that the shrimp can freely ingest the King Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain, thereby allowing the King Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain to work together to enhance the shrimp's immune ability (for example, enhance the lysozyme activity of blood cells), so that when the shrimp is infected by pathogens such as Vibrio alginolyticus, the shrimp can be less likely to die from the attack of pathogens.
舉例而言,工者可以將該組合物添加於一飼料中,以與該飼料共同形成一混合物(例如使每公斤的混合物中包含5~6公克的杏鮑菇萃取物及10 8CFU的植物乳桿菌7-40菌株)。接著,工者可以選用重量約為0.35~0.37公克之蝦體,並連續將該混合物投於養殖水中56~60天,供該蝦體可以自由攝食,使該杏鮑菇萃取物係以每天每公克之蝦體重投予300 μg之劑量投予該蝦體,且該植物乳桿菌7-40菌株以每天每公克之蝦體重投予6,000 CFU之劑量投予該蝦體。 For example, workers can add the composition to a feed to form a mixture with the feed (for example, each kilogram of the mixture includes 5 to 6 grams of Pleurotus eryngii extract and 10 8 CFU of plant Lactobacillus strain 7-40). Then, workers can select shrimp bodies weighing about 0.35 to 0.37 grams, and continuously put the mixture into the culture water for 56 to 60 days, so that the shrimp bodies can eat freely, so that the Pleurotus eryngii extract can be consumed every day. A dose of 300 μg per gram of shrimp body weight was administered to the shrimp body, and the Lactobacillus plantarum 7-40 strain was administered to the shrimp body at a dose of 6,000 CFU per gram of shrimp body weight per day.
舉例而言,工者可以選用如第1表所示的飼料的配方,且在加入該組合物時,係分別以該杏鮑菇萃取物及該植物乳桿菌7-40菌株取代等量的脫脂奶粉及纖維素。For example, a worker may select the feed formula shown in Table 1, and when adding the composition, replace the same amount of skimmed milk powder and cellulose with the King Oyster Mushroom extract and the Lactobacillus plantarum 7-40 strain, respectively.
第1表、飼料的配方(1公斤)
為證實本發明之組合物確實具有提升蝦體免疫能力的活性,遂進行以下試驗:In order to confirm that the composition of the present invention indeed has the activity of improving the immunity of shrimps, the following tests were carried out:
(A)杏鮑菇萃取物的製備(A) Preparation of King Oyster Mushroom Extract
本試驗係取500公克的杏鮑菇菌托樣品,混合1,000毫升的去離子水,倒入2,000毫升的玻璃燒杯中,並以鋁箔覆蓋住該玻璃燒杯的開口,接著煮沸15分鐘。在冷卻至室溫之後,將該混合物於4℃的溫度下進行離心(14,400×g)20分鐘,收取上清液之後,再次煮沸15分鐘,並且冷卻至室溫後,儲存於4℃的溫度下備用,如此即可以獲得體積約為1000毫升、重量約為500公克的杏鮑菇萃取液,經乾燥去除水分之後可以獲得約為5公克的杏鮑菇萃取物。In this test, 500 grams of Pleurotus eryngii mushroom base sample was mixed with 1,000 ml of deionized water, poured into a 2,000 ml glass beaker, the opening of the glass beaker was covered with aluminum foil, and then boiled for 15 minutes. After cooling to room temperature, the mixture was centrifuged (14,400 × g) at 4°C for 20 minutes. The supernatant was collected, boiled again for 15 minutes, cooled to room temperature, and stored at 4°C. In this way, a Pleurotus eryngii extract with a volume of about 1000 ml and a weight of about 500 grams can be obtained. After drying and removing the water, about 5 grams of Pleurotus eryngii extract can be obtained.
(B)杏鮑菇萃取物對植物乳桿菌7-40菌株的生長促進效果(B) Growth-promoting effect of Pleurotus eryngii extract on Lactobacillus plantarum 7-40 strain
本試驗係選用如第2表所示的細菌,將200 μL的細菌母液(約含2×10 8CFU的微生物)轉移至20毫升的杏鮑菇萃取物中,將該植物乳桿菌7-40菌株培養於37℃的溫度下24小時;溶藻弧菌、副溶血弧菌及哈維氏弧菌則培養於27℃的溫度下24小時,並且於培養的第6、12、24小時的時間點計算各細菌的濃度。 This test uses the bacteria shown in Table 2. 200 μL of bacterial stock solution (containing approximately 2×10 8 CFU of microorganisms) is transferred to 20 ml of Pleurotus eryngii extract. The Lactobacillus plantarum 7-40 The strains were cultured at 37°C for 24 hours; Vibrio alginolyticus, Vibrio parahaemolyticus and Vibrio harveyi were cultured at 27°C for 24 hours, and at the 6th, 12th and 24th hours of culture Calculate the concentration of each bacteria.
第2表、本試驗各組的細菌
請參照第1圖所示,僅有第B1組的植物乳桿菌7-40菌株在以該杏鮑菇萃取物進行培養時能夠持續生長,且於第24小時的時間點時,與第B2組的溶藻弧菌、第B3組的副溶血弧菌及第B4組的哈維氏弧菌的細菌濃度均具有顯著差異( P<0.05)。 As shown in Figure 1, only the Lactobacillus plantarum 7-40 strain in Group B1 was able to continue growing when cultured with the Pleurotus eryngii extract, and at the 24th hour point, the bacterial concentrations of the strains were significantly different from those of the Vibrio alginolyticus in Group B2, the Vibrio parahaemolyticus in Group B3, and the Vibrio harveyi in Group B4 ( P < 0.05).
又,選用從國立屏東科技大學水產養殖系教學實習場取得的太平洋白蝦(平均體重為0.35~0.37公克),先將該太平洋白蝦置於實驗室養殖一週,使該太平洋白蝦適應試驗養殖環境(海水環境,鹽度為25 ppt;水溫為28±1℃;pH值為8±0.05),並於禁食一天之後,進行後續試驗:In addition, Pacific white shrimp (average weight 0.35-0.37 g) obtained from the teaching and practice field of the Department of Aquaculture of National Pingtung University of Science and Technology were selected and cultured in the laboratory for one week to adapt to the experimental culture environment (seawater environment,
(C)對免疫因子的影響(C)Effects on immune factors
請參照第3表所示,本試驗係以該植物乳桿菌7-40菌株取代該飼料中的脫脂奶粉,以作為用以餵食第C2組太平洋白蝦的混合物;以該杏鮑菇萃取物取代該飼料中的纖維素,以作為用以餵食第C3組太平洋白蝦的混合物;以該植物乳桿菌7-40菌株、該杏鮑菇萃取物分別取代該飼料中的脫脂奶粉、纖維素,以作為用以餵食第C4組太平洋白蝦的混合物;另以第1表所示的飼料做為用以餵食第C1組太平洋白蝦的混合物,將前述混合物投於養殖水中,供該太平洋白蝦可以自由攝食,並且連續使該太平洋白蝦自由攝食前述混合物56~60天。As shown in Table 3, in this test, the skimmed milk powder in the feed was replaced by the plant lactobacillus 7-40 strain to form a mixture for feeding Pacific white shrimps in Group C2; the cellulose in the feed was replaced by the King Pleurotus ostreatus extract to form a mixture for feeding Pacific white shrimps in Group C3; the skimmed milk powder and cellulose in the feed were replaced by the plant lactobacillus 7-40 strain and the King Pleurotus ostreatus extract respectively to form a mixture for feeding Pacific white shrimps in Group C4; and the feed shown in Table 1 was used as a mixture for feeding Pacific white shrimps in Group C1. The above mixture was added to the culture water for free intake by the Pacific white shrimps, and the Pacific white shrimps were allowed to freely intake the above mixture for 56 to 60 consecutive days.
第3表、本試驗各組之混合物中的添加物
接著,自頭胸甲腹面的血竇處抽取血淋巴(hemolymph),將血淋巴以1:9之體積比加入﹝內含30 mM的檸檬酸鈉(trisodium citrate)、0.34 M的氯化鈉(NaCl,sodium chloride)及10 mM的乙二胺四乙胺(ethylenediaminetetraacetic acid,EDTA),以鹽酸(HCl)水溶液及/或氫氧化鈉(NaOH)水溶液將pH調整為7.5,並以氯化鈉將滲透壓調整為780 mOsm/kg﹞,混合均勻以獲得包含抗凝劑的血淋巴混合液。Next, hemolymph was extracted from the blood sinus on the ventral surface of the cephalothorax, and the hemolymph was added at a volume ratio of 1:9 (containing 30 mM sodium citrate (trisodium citrate), 0.34 M sodium chloride ( NaCl, sodium chloride) and 10 mM ethylenediaminetetraacetic acid (EDTA), adjust the pH to 7.5 with hydrochloric acid (HCl) aqueous solution and/or sodium hydroxide (NaOH) aqueous solution, and use sodium chloride to The osmotic pressure is adjusted to 780 mOsm/kg﹞, and the hemolymph mixture containing anticoagulant is obtained by mixing evenly.
將該血淋巴混合液離心去除上清液之後,加入1 mL、0.1 M的磷酸鹽緩衝生理鹽水﹝sodium phosphate buffer,PBS buffer;內含22.5 mM的磷酸一氫鈉(sodium hydrogen phosphate,Na 2HPO 4)及77.5 mM的磷酸二氫鈉(sodium dihydrogen phosphate,NaH 2PO 4),以磷酸一氫鈉水溶液及/或磷酸二氫鈉水溶液將pH值調整為6.2﹞進行清洗,去除上清液之後再回溶於50 μL的磷酸鹽緩衝生理鹽水,在以超音波破碎儀進行破碎之後,即可以取得血球細胞均質液。 After the hemolymph mixture is centrifuged and the supernatant is removed, 1 mL of 0.1 M phosphate buffered saline (sodium phosphate buffer, PBS buffer; containing 22.5 mM sodium hydrogen phosphate (Na 2 HPO 4 ) and 77.5 mM sodium dihydrogen phosphate (NaH 2 PO 4 ), the pH value is adjusted to 6.2 with sodium hydrogen phosphate aqueous solution and/or sodium dihydrogen phosphate aqueous solution) is added for washing. After removing the supernatant, it is re-dissolved in 50 μL of phosphate buffered saline and disrupted with an ultrasonic disruptor to obtain a blood cell homogenate.
取10 μL的血球細胞均質液置於96孔盤中,並與200 μL的藤黃微球菌( Micrococcus luteus)菌液混合,偵測於反應第30秒及第5分鐘的時間點下,於530 nm波長下的吸光值,以換算溶菌酶的活性。結果如第2圖所示,投予本發明之組合物的第C4組太平洋白蝦的溶菌酶活性有顯著提升,且效果顯著優於僅投予該植物乳桿菌7-40菌株的第C2組太平洋白蝦及僅投予該杏鮑菇萃取物的第C3組太平洋白蝦( P<0.05)。 Take 10 μL of blood cell homogenate and place it in a 96-well plate, mix it with 200 μL of Micrococcus luteus bacterial solution, and detect at the time points of 30 seconds and 5 minutes of reaction, at 530 The absorbance value at nm wavelength is used to convert the activity of lysozyme. The results are shown in Figure 2. The lysozyme activity of group C4 of Pacific white shrimps administered the composition of the present invention was significantly improved, and the effect was significantly better than that of group C2 of group C4 only administered the Lactobacillus plantarum 7-40 strain. Pacific white shrimp and Group C3 Pacific white shrimp that were only administered the Pleurotus eryngii extract ( P <0.05).
(D)溶藻弧菌感染之後的存活率(D)Survival rate after infection with Vibrio alginolyticus
接著,再請參照第4表所示,本試驗同樣將前述混合物投於養殖水中,供該太平洋白蝦可以自由攝食,並且於連續使該太平洋白蝦自由攝食前述混合物56天之後,分別以溶藻弧菌注射各組太平洋白蝦,使該太平洋白蝦感染溶藻弧菌(感染劑量為1.5×10 5CFU/公克蝦體),並於0、24、48、72及96小時分別計算各組太平洋白蝦的死亡率。 Next, please refer to Table 4. In this experiment, the aforementioned mixture was also put into the culture water so that the Pacific white shrimp could freely eat. After continuously allowing the Pacific white shrimp to freely eat the aforementioned mixture for 56 days, the mixture was dissolved in solution. Each group of Pacific white shrimps was injected with Vibrio alginolyticus to infect the Pacific white shrimps with Vibrio alginolyticus (infectious dose was 1.5×10 5 CFU/g shrimp body), and each group was calculated at 0, 24, 48, 72 and 96 hours. Mortality of group Pacific white shrimp.
第4表、本試驗各組之混合物中的添加物
請參照第3圖所示,投予本發明之組合物的第D4組太平洋白蝦於第24~96小時內的死亡率均有顯著地降低,其中於第96小時的時間點的存活率仍可以達約95%,顯示本發明之組合物可以有效預防溶藻弧菌的感染,降低太平洋白蝦受到溶藻弧菌的感染而死亡的風險。As shown in Figure 3, the mortality rate of Pacific white shrimp in Group D4 administered with the composition of the present invention was significantly reduced within 24 to 96 hours, and the survival rate at the 96th hour time point was still the same. It can reach about 95%, indicating that the composition of the present invention can effectively prevent infection by Vibrio alginolyticus and reduce the risk of death of Pacific white shrimp due to infection by Vibrio alginolyticus.
綜上所述,本發明的組合物包含該杏鮑菇萃取物及該植物乳桿菌7-40菌株,因此可以藉由二者的加乘作用,達成有效提升蝦類的免疫能力之功效。In summary, the composition of the present invention comprises the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain, and thus can achieve the effect of effectively enhancing the immunity of shrimps through the synergistic effect of the two.
再且,本發明的組合物的用途,係藉由該杏鮑菇萃取物及該植物乳桿菌7-40菌株的共同使用,可以促進蝦類的細胞免疫反應(例如提升血球細胞溶菌酶活性),因此當受到溶藻弧菌等病原菌的感染時,可以降低蝦類遭受病原菌攻擊所造成之死亡,是以可以降低養殖業者於養殖過程中的抗生素使用量,為本發明之功效。Furthermore, the use of the composition of the present invention is to promote the cellular immune response of shrimp (such as increasing the lysozyme activity of blood cells) through the joint use of the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain. , therefore when infected by pathogenic bacteria such as Vibrio alginolyticus, it can reduce the death of shrimps caused by pathogenic bacteria attack, so it can reduce the amount of antibiotics used by farmers in the breeding process, which is the effect of the present invention.
此外,本發明的組合物的用途,係以該杏鮑菇菌托樣品作為原料,使原本被認定為農業廢棄物的菌托具有新的經濟價值,達成為菌托創造新的經濟出路之功效。In addition, the use of the composition of the present invention is to use the Pleurotus eryngii mushroom tray sample as a raw material to give the mushroom tray that was originally recognized as agricultural waste a new economic value and achieve the effect of creating a new economic outlet for the mushroom tray. .
雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當包含後附之申請專利範圍所記載的文義及均等範圍內之所有變更。Although the present invention has been disclosed using the above-mentioned preferred embodiments, they are not intended to limit the present invention. Any person skilled in the art may make various changes and modifications to the above-mentioned embodiments without departing from the spirit and scope of the present invention, and the scope of protection of the present invention shall include all changes within the meaning and equivalent scope recorded in the attached patent application.
無without
[第1圖] 試驗(B)中,第B1~B4組微生物的濃度變化圖。 [第2圖] 試驗(C)中,第C1~C4組太平洋白蝦之血球細胞的溶菌酶活性。 [第3圖] 試驗(D)中,第D1~D4組太平洋白蝦於96小時內的累積死亡率。 [Picture 1] Concentration changes of microorganisms in groups B1 to B4 in test (B). [Picture 2] In test (C), lysozyme activity of hemocytes of Pacific white shrimp in groups C1 to C4. [Picture 3] In experiment (D), the cumulative mortality rate of Pacific white shrimp in groups D1 to D4 within 96 hours.
國內寄存資訊 植物乳桿菌7-40:中華民國食品工業發展研究所、2022年05月12日、BCRC 911128。 Domestic storage information Lactobacillus plantarum 7-40: Institute of Food Industry Development of the Republic of China, May 12, 2022, BCRC 911128.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111130782A TWI820864B (en) | 2022-08-16 | 2022-08-16 | Composition for boosting immunity and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111130782A TWI820864B (en) | 2022-08-16 | 2022-08-16 | Composition for boosting immunity and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI820864B TWI820864B (en) | 2023-11-01 |
TW202408557A true TW202408557A (en) | 2024-03-01 |
Family
ID=89722275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111130782A TWI820864B (en) | 2022-08-16 | 2022-08-16 | Composition for boosting immunity and use thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI820864B (en) |
-
2022
- 2022-08-16 TW TW111130782A patent/TWI820864B/en active
Also Published As
Publication number | Publication date |
---|---|
TWI820864B (en) | 2023-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Macey et al. | Improved growth rate and disease resistance in farmed Haliotis midae through probiotic treatment | |
Sarlin et al. | Efficacy of marine yeasts and baker's yeast as immunostimulants in Fenneropenaeus indicus: a comparative study | |
Zhao et al. | Effects of dietary supplementation of probiotics on growth, immune responses, and gut microbiome of the abalone Haliotis diversicolor | |
Wang et al. | Enhancement of non-specific immune response in sea cucumber (Apostichopus japonicus) by Astragalus membranaceus and its polysaccharides | |
Luis-Villaseñor et al. | Beneficial effects of four Bacillus strains on the larval cultivation of Litopenaeus vannamei | |
Chandrakala et al. | Vibriosis in shrimp aquaculture a review | |
CN103385381B (en) | Special compound feed for litopenaeus vannamei | |
Partida-Arangure et al. | Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei cultured under laboratory conditions | |
CN108289479A (en) | Composition for aquaculture and/or combination | |
Van Doan et al. | Administration of watermelon rind powder to Nile tilapia (Oreochromis niloticus) culture under biofloc system: Effect on growth performance, innate immune response, and disease resistance | |
KR101663570B1 (en) | Feed additive containing Pyeong wee-San sludge extract and functional feed using thereof | |
Harikrishnan et al. | Effect of Agaricus bisporus enriched diet on growth, hematology, and immune protection in Clarias gariepinus against Flavobacterium columnare | |
Sahoo et al. | Nutritional and biological control synergism against gastrointestinal nematodes in small ruminants | |
CN107821739A (en) | The application of composite feed additive, the preparation method of antivirotic and antivirotic | |
CN113403222B (en) | Lactobacillus acidophilus, aquatic feed additive, fish feed and application of lactobacillus acidophilus and aquatic feed additive | |
CN103315151A (en) | Special feed additive for South American white shrimp | |
Chotikachinda et al. | Effect of inactive yeast cell wall on growth performance, survival rate and immune parameters in Pacific White Shrimp (Litopenaeus vannamei). | |
TWI820864B (en) | Composition for boosting immunity and use thereof | |
CN111676197A (en) | Vibrio harveyi phage, phage composition and application thereof | |
CN105104715A (en) | Feed preventing vibrio infection of xenocypris davidi and preparation method thereof | |
CN105380939A (en) | Genistein and application of medicinal derivative thereof in preparation of medicine for resisting eimeria tenella | |
KR20170001379A (en) | Inactivated vaccine composition against atypical Aeromonas salmonicida in rockfish | |
Jueliang et al. | The effects of probiotic, β-1, 3-glucan and organic acid on Pacific white shrimp’s (Litopenaeus vannamei) immune system and survival upon challenge with Vibrio harveyi | |
Khatun et al. | Effect of different probiotics on growth, survival and production of monosex Nile tilapia (Oreochromis niloticus) | |
TWI832304B (en) | Use of extract of mangosteen husk |